Transradial Access Market Industry Research and End User Analysis By 2025: BD, Cardinal Health, Terumo Medical Corporation, Teleflex Incorporated, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Merit Medical Systems, Inc., Oscor Inc., AngioD

There are several recent developments, product launches, joint ventures, merges and accusations by the key market players and brands who will dominate the transradial access market and hence Healthcare IT industry for the forecast years 2018 to 2025.

This report has all the company profiles for the top players and brands and along with that the report also contains a synopsis of market definition, classifications, applications and market trends, and the transradial access market drivers and restrains that are derived from a well know method called SWOT analysis.

To request a free sample copy or view summary of this report, click the link below @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-transradial-access-market

The global transradial access market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Cardinal Health dominates transradial access market, accounting for the highest market share in 2017, followed by Stryker and Angiodynamics Inc. Other players in this market include BD, Terumo Corporation, Teleflex Incorporated, Smiths Group plc, MEDTRONIC, Boston Scientific Corporation, Edwards Lifesciences Corporation, Merit Medical Systems Inc., NIPRO CORPORATION, Amecath, OSCOR Inc. and Penumbra among others holds 7.8% of the global transradial access system market in 2017.

Cardinal Health:

Cardinal Health was founded in 1979 and headquartered at Ohio, U.S. The company offers its integrated healthcare services and products to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide.

The company operates through two business segments–medical segment and pharmaceutical segment. Medical business segment manufactures and distributes medical, surgical and laboratory products including cardiovascular and endovascular products, wound care products, single-use surgical drapes, gowns and apparel, exam and surgical gloves, and fluid suction and collection systems. In 2015, Cardinal Health acquired Cordis business of Johnson & Johnson for their cardiovascular and endovascular product portfolio. All transradial access products including guidewire, catheters fall under cardiovascular segment.

The company has its network in more than 60 countries worldwide including U.S., Australia, Japan, Canada, China, Puerto Rico and other Europe, Middle East, Africa countries. Some of company’s subsidiaries are Cordis Corporation (U.S.), RGH Enterprises, Inc. (U.S.), Source Medical Corp (Canada), CareFusion (U.S.), Medicine Shoppe International, Inc (U.S.), Viasys Healthcare (U.S.), Tecomet, Inc (U.S.) among others.

Recent Developments:

In October, 2015, Cardinal Health completed the acquisition of Johnson & Johnson’s Cordis business for cardiology and endovascular devices. This acquisition enhanced the Cardinal Health product portfolio by offering products in the cardiovascular, wound management, and orthopedics segment.

Stryker:

Established in 1941 and headquartered at Michigan, U.S. Stryker is a one of the leading medical technologies company. The company provides products through three business segment Neurotechnology and Spine, MedSurg and Orthopaedics. The Neurotechnology and Spine segment offering include products related to neurotechnology.

These are utilized in minimally invasive endovascular procedures, minimally invasive products for hemorrhagic stroke and acute ischemic treatment, biosurgery and orthobiologic products such as vertebral augmentation and synthetic bone grafts products and others. Its products are identified on the web site in accordance with 35 U.S.C. § 287(a) by relating each known product with one or more patents.

Browse Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=global-transradial-access-market

Drivers: Global Transradial Access Market

The major factors driving the growth of this market are increasing cases of obese patient, rising number of heart problems, growing use of radial access in oncology field and technological advancements. On the other hand product recalls and failures may hinder the growth of the market are the factors which will boost the global transradial access market.

INCREASING CASES OF OBESE PATIENTS :

Obesity is the rising concern worldwide. The prevalence of obesity among children and adolescents aged 5-19 were valued to be raised by 18.0% in 2016 from previous year. The basic cause of obesity is an energy disparity among calories consumed and calories expended. Also, the surge of physical dormancy and consumption of energy-dense foods that are high in fat are major causes that leads to obesity. Moreover, obesity is also a risk factor for high cholesterol which leads to numerous heart problems. Following are some related stats of obesity:

According to American Heart Association (AHA), in the U.S. more than one-third (approximately 35.0%) of adults are obese (over 78 million adults).
According to Heart Foundation, in 2011, the prevalence of high cholesterol increases in the age of 55 to 64 years, and half of the population among them have high total cholesterol level.

According to the National Health and Nutrition Examination Survey (NHANES), the study reports that, in 2013-2014 more than 1 in 3 adults were considered to be obese. In which about 1 in 6 children and adolescents ages 2 to 19 were considered to have obesity.

Transradial access procedure is extensively used in obese patients as it aids to identify and control procedural hemorrhage. A recent study shows that transradial access has effectively reduced vascular problems in patients who were overweight. Also, transradial access offers less morbidity and bleeding complications associated to transfemoral access in percutaneous coronary interventions for obese people. Therefore, the augmented cases of obese patients are choosing transradial access process for treatment, eventually spurring the market demand.

RISING NUMBER OF HEART PROBLEMS:

Cardiovascular diseases (CVDs) are the disorders that affect the heart and blood vessels and it leads to cerebrovascular diseases, coronary heart diseases, rheumatic heart diseases and other conditions. The individuals with cardiovascular ailments are at a higher risk of certain issues such as glucose, blood pressure and lipids, overweight and obesity. The increased cholesterol levels and obesity are the major factors that results in augmentation of heart diseases. Some of the statistics for cardiovascular disease are mentioned below:

According to Centers for Disease Control and Prevention (CDC),
approximately 610,000 people die due to heart disease in the U.S. per year.
According to European Heart Network, every year cardiovascular disease leads to 3.9 million deaths in Europe and around 1.8 million deaths in the European Union.

According to World Health Organization (WHO), cardiovascular disease (CVD) causes more than half of all deaths across the European Region. The disease leads to death or frequently it is caused by AIDS, tuberculosis and malaria combined in Europe.

Any specific requirements are you looking for? Ask to your Industry Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-transradial-access-market

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.